00:00:00Thank you for listening.
00:00:30Thank you for listening.
00:01:00C'est plutôt grand.
00:01:04C'est plutôt grand.
00:01:34C'est plutôt grand.
00:02:04D'où venez-vous ?
00:02:16Pardon.
00:02:18C'est plutôt grand.
00:02:48C'est plutôt grand.
00:03:18C'est plutôt grand.
00:03:48C'est plutôt grand.
00:04:18C'est plutôt grand.
00:04:48C'est plutôt grand.
00:05:18C'est plutôt grand.
00:06:18C'est plutôt grand.
00:06:48C'est plutôt grand.
00:07:18C'est plutôt grand.
00:07:20C'est plutôt grand.
00:07:50C'est plutôt grand.
00:07:52C'est plutôt grand.
00:07:54C'est plutôt grand.
00:07:56C'est plutôt grand.
00:07:58C'est plutôt grand.
00:08:00C'est plutôt grand.
00:08:04C'est plutôt grand.
00:08:06C'est plutôt grand.
00:08:08Ah, c'est grand.
00:08:10C'est plutôt grand.
00:08:12C'est grand.
00:08:14C'est grand.
00:08:16C'est grand.
00:08:18C'est grand.
00:08:20C'est grand.
00:08:22C'est grand.
00:08:24C'est grand.
00:08:26C'est grand.
00:08:28C'est grand.
00:08:30C'est grand.
00:08:32C'est grand.
00:08:34C'est grand.
00:08:35C'est grand.
00:08:36C'est grand.
00:09:40Including the investigation of the incidence, risk factors and monitoring for adverse drug
00:09:46reactions that can be detected with a biochemical test, such as drug-induced blood disorders,
00:09:52and the identification of potential biomarkers for adverse drug reactions.
00:09:56So, the objective of this research is to investigate the value of laboratory data collected in patient care.
00:10:03What is it? Is it a phone?
00:10:08Sorry.
00:10:10Oh, that's nice. I didn't know there's a ringtone like that. I like it.
00:10:13Yeah. Now we focus on drug-induced thrombocytopenia as an example.
00:10:23First, we investigated...
00:10:25I did...
00:10:27I don't know.
00:10:29I don't know.
00:10:31I don't know.
00:10:37I don't know.
00:10:39I didn't know.
00:10:40I don't know.
00:10:41I don't know.
00:30:42Thanks.
00:36:42And his face.
00:52:41Okay.
01:00:11Simon.
01:03:41That's good.
Comments